Bertold J. Vilner

1.5k total citations
16 papers, 1.2k citations indexed

About

Bertold J. Vilner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Bertold J. Vilner has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Bertold J. Vilner's work include Pharmacological Receptor Mechanisms and Effects (15 papers), Receptor Mechanisms and Signaling (11 papers) and Neuropeptides and Animal Physiology (8 papers). Bertold J. Vilner is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (15 papers), Receptor Mechanisms and Signaling (11 papers) and Neuropeptides and Animal Physiology (8 papers). Bertold J. Vilner collaborates with scholars based in United States. Bertold J. Vilner's co-authors include Christy S. John, Wayne D. Bowen, W D Bowen, Brian C. Geyer, W. Don Bowen, Craig M. Bertha, Terry W. Moody, Kenner C. Rice, Martin E. Kuehne and Arthur E. Jacobson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Bertold J. Vilner

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertold J. Vilner United States 15 1.1k 546 210 88 55 16 1.2k
Suwanna Vangveravong United States 23 1.2k 1.1× 515 0.9× 308 1.5× 35 0.4× 96 1.7× 38 1.5k
Justin M. Rothfuss United States 15 720 0.7× 157 0.3× 250 1.2× 97 1.1× 112 2.0× 18 973
Erika A. Currier United States 17 469 0.4× 335 0.6× 127 0.6× 25 0.3× 30 0.5× 26 851
Nisha K. Ramakrishnan Netherlands 12 401 0.4× 190 0.3× 65 0.3× 80 0.9× 84 1.5× 29 599
Helmut Mack Germany 16 533 0.5× 329 0.6× 280 1.3× 19 0.2× 90 1.6× 23 1.1k
Stacey O’Malley United States 18 291 0.3× 227 0.4× 211 1.0× 153 1.7× 104 1.9× 36 769
Anna A. Rybczynska Netherlands 12 402 0.4× 136 0.2× 74 0.4× 48 0.5× 93 1.7× 20 566
Ewa Grajkowska United States 14 417 0.4× 382 0.7× 95 0.5× 85 1.0× 64 1.2× 22 730
Fredric J. Vinick United States 10 687 0.6× 650 1.2× 191 0.9× 20 0.2× 91 1.7× 25 1.0k
Chunyang Jin United States 14 310 0.3× 173 0.3× 170 0.8× 37 0.4× 67 1.2× 47 579

Countries citing papers authored by Bertold J. Vilner

Since Specialization
Citations

This map shows the geographic impact of Bertold J. Vilner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertold J. Vilner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertold J. Vilner more than expected).

Fields of papers citing papers by Bertold J. Vilner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertold J. Vilner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertold J. Vilner. The network helps show where Bertold J. Vilner may publish in the future.

Co-authorship network of co-authors of Bertold J. Vilner

This figure shows the co-authorship network connecting the top 25 collaborators of Bertold J. Vilner. A scholar is included among the top collaborators of Bertold J. Vilner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertold J. Vilner. Bertold J. Vilner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vilner, Bertold J. & Wayne D. Bowen. (2000). Modulation of Cellular Calcium by Sigma-2 Receptors: Release from Intracellular Stores in Human SK-N-SH Neuroblastoma Cells. Journal of Pharmacology and Experimental Therapeutics. 292(3). 900–911. 166 indexed citations
2.
John, Christy S., Wayne D. Bowen, Susan J. Fisher, et al.. (1999). Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer. Nuclear Medicine and Biology. 26(4). 377–382. 29 indexed citations
3.
John, Christy S., Bertold J. Vilner, Brian C. Geyer, Terry W. Moody, & W D Bowen. (1999). Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.. PubMed. 59(18). 4578–83. 89 indexed citations
4.
Husbands, Stephen M., Sari Izenwasser, Theresa Kopajtic, et al.. (1999). Structure−Activity Relationships at the Monoamine Transporters and σ Receptors for a Novel Series of 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)-propyl]carbazole (Rimcazole) Analogues. Journal of Medicinal Chemistry. 42(21). 4446–4455. 38 indexed citations
5.
John, Christy S., et al.. (1998). Substituted Halogenated Arylsulfonamides:  A New Class of σ Receptor Binding Tumor Imaging Agents. Journal of Medicinal Chemistry. 41(14). 2445–2450. 22 indexed citations
6.
John, Christy S., et al.. (1997). 99mTc-Labeled σ-Receptor-Binding Complex:  Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells. Bioconjugate Chemistry. 8(3). 304–309. 27 indexed citations
7.
Husbands, Stephen M., Sari Izenwasser, Richard Loeloff, et al.. (1997). Isothiocyanate Derivatives of 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]- carbazole (Rimcazole):  Irreversible Ligands for the Dopamine Transporter. Journal of Medicinal Chemistry. 40(26). 4340–4346. 21 indexed citations
8.
9.
Bowen, W. Don, Craig M. Bertha, Bertold J. Vilner, & Kenner C. Rice. (1995). CB-64D and CB-184: ligands with high σ2 receptor affinity and subtype selectivity. European Journal of Pharmacology. 278(3). 257–260. 52 indexed citations
10.
Bowen, Wayne D., et al.. (1995). Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity. European Journal of Pharmacology. 279(1). R1–R3. 75 indexed citations
11.
Bertha, Craig M., Bertold J. Vilner, Mariena V. Mattson, et al.. (1995). (E)-8-Benzylidene Derivatives of 2-Methyl-5-(3-hydroxyphenyl)morphans: Highly Selective Ligands for the .sigma.2 Receptor Subtype. Journal of Medicinal Chemistry. 38(24). 4776–4785. 10 indexed citations
12.
John, Christy S., et al.. (1995). Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.. PubMed. 55(14). 3022–7. 52 indexed citations
13.
Vilner, Bertold J., Christy S. John, & W D Bowen. (1995). Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.. PubMed. 55(2). 408–13. 421 indexed citations
14.
John, Christy S., Bertold J. Vilner, & Wayne D. Bowen. (1994). Synthesis and Characterization of [125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide, a New .sigma. Receptor Radiopharmaceutical: High-Affinity Binding to MCF-7 Breast Tumor Cells. Journal of Medicinal Chemistry. 37(12). 1737–1739. 60 indexed citations
15.
Vilner, Bertold J. & Wayne D. Bowen. (1993). σ Receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture. European Journal of Pharmacology Molecular Pharmacology. 244(2). 199–201. 64 indexed citations
16.
John, Christy S., W. Don Bowen, Seigo Kinuya, et al.. (1993). A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.. PubMed. 34(12). 2169–75. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suwanna Vangveravong Breakdown of academic impact, for papers by Justin M. Rothfuss Breakdown of academic impact, for papers by Erika A. Currier Breakdown of academic impact, for papers by Nisha K. Ramakrishnan Breakdown of academic impact, for papers by Helmut Mack Breakdown of academic impact, for papers by Stacey O’Malley Breakdown of academic impact, for papers by Anna A. Rybczynska Breakdown of academic impact, for papers by Ewa Grajkowska Breakdown of academic impact, for papers by Fredric J. Vinick Breakdown of academic impact, for papers by Chunyang Jin
Rankless by CCL
2026